Skip to main content
Fachgebiete
Automobil + Motoren Bauwesen + Immobilien Business IT + Informatik Elektrotechnik + Elektronik Energie + Nachhaltigkeit Finance + Banking Management + Führung Marketing + Vertrieb Maschinenbau + Werkstoffe Versicherung + Risiko
DE
EN
Themenseiten
Organisationspsychologie Projektmanagement Marketing Smart Manufacturing
Bücher
Zeitschriften
Weitere Formate
Podcasts Webinare Technik Webinare Wirtschaft Kongresse Veranstaltungskalender Awards
Jetzt Einzelzugang starten
Zugang für Unternehmen
Referenzkunden
ATZ-Fachkongress

Chassis.tech plus 2024


4 Kongresse in einer Veranstaltung

Treffen Sie in München die Fachleute von Chassis, Lenkung, Bremsen sowie Reifen/Räder.
Erweiterte Suche
Anmelden
nach oben
Erschienen in:
What is Integrated Care? Kapitel lesen Erstes Kapitel lesen

2021 | OriginalPaper | Buchkapitel

27. Polypharmacy and Integrated Care

verfasst von : Alpana Mair, Albert Alonso

Erschienen in: Handbook Integrated Care

Verlag: Springer International Publishing

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Safe and effective pharmacological treatment remains one of the greatest challenges in medicine, where models of healthcare delivery lag behind the enormous growth in single disease focused treatment with medicines. The implications for safe, efficient and effective deployment of healthcare resources and sustainability are significant from both healthcare and societal perspectives. This chapter will highlight the importance of addressing the public health issue of polypharmacy as part of an integrated approach to patient care and its impact on patient safety. It will describe a 7 step process for systematic review of appropriateness of patient’s medication with multiple morbidities, that is patient centered and encourages the patient to be part of the decision making.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Jetzt informieren
Vorheriges Kapitel Discharge and Transition Management in Integrated Care
Nächstes Kapitel Digital Health Systems in Integrated Care
Literatur
Am. Geriatr. Soc. Beers Criteria Update Expert Panel. (2015). American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in adults. Journal of the American Geriatrics Society, 63, 2227–2246.CrossRef
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet, 380(9836), 37–43.CrossRef
Benetos, A., Labat, C., Rossignol, P., Fay, R., Rolland, Y., et al. (2015). Treatment with multiple blood pressure medications, achieved blood pressure, and mortality in older nursing home residents. JAMA Internal Medicine, 175(6), 989–995.CrossRef
Bishara, D., Harwood, D., Sauer, J., & Taylor, D. (2016). Anticholinergic effect on cognition (AEC) of drugs commonly used in older people. International Journal of Geriatric Psychiatry, 32(6), 650–656.CrossRef
Chang, Y.-P., Huang, S.-K., Tao, P., et al. (2012). A population-based study on the association between acute renal failure (ARF) and the duration of polypharmacy. BMC Nephrology, 13(1), 96.CrossRef
Clegg, A., Bates, C., Young, J., Ryan, R., Nichols, L., et al. (2016). Development and validation of an electronic frailty index using routine primary care electronic health record data. Age and Ageing, 45(3), 353–360.CrossRef
Clegg, A., Young, J., Iliffe, S., Rikkert, M. O., & Rockwood, K. (2013). Frailty in elderly people. Lancet, 381, 752–762.CrossRef
Craig, P., Dieppe, P., Macintyre, S., Michie, S., Nazareth, I., & Petticrew, M. (2006). Developing and evaluating complex interventions: New guidance. The Medical Research Council.
Darowski, A., & Whiting, R. (2011). Cardiovascular drugs and falls. Reviews in Clinical Gerontology, 21(2), 170–179.CrossRef
Duerden, M., Avery, T., & Payne, R. (2013). Polypharmacy and medicines optimization: Making it safe and sound. London: The King’s Fund.
Dumbreck, S., Flynn, A., Nairn, M., et al. (2015). Drug-disease and drug-drug interactions: Systematic examination of recommendations in 12 UK national clinical guidelines. BMJ, 350, h949.CrossRef
Effect Prescribing and Therapeutics. (2020). Digital health & care innovation centre (DHI). Polypharmacy: Manage medicines (version 3.0.30{Mobile app]).
Elliott, R. (2009). Non-adherence to medicines: Not solved but solvable. Journal of Health Services Research and Policy, 14(1), 58–61.CrossRef
Hansen, M. L., Sorensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunso, J., et al. (2010). Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Archives of Internal Medicine, 170(16), 1433–1441.CrossRef
Hayward, K. L., et al. (2016). Prevalence of medication discrepancies in patients with cirrhosis: A pilot study. BMC Gastroenterology, 16, 114.CrossRef
Kirke, C., WHO. (2019). Medication sfatey in transitions of care. Geneva. World Health Org. KotterInternational. Kotters 8 step process for leading change.
Köberlein, J., & Jürges, H. (2013). Multimorbidity, incentives and the use of health services in Europe. In A. Börsch-Supan, M. Brandt, H. Litwin, & G. Weber (Eds.), Active ageing and solidarity between generations in Europe: First results from share after the economic crisis (pp. 243–252). Berlin: de Gruyter.
Kongkaew, C., Hann, M., Mandal, J., Williams, S. D., Metcalfe, D., et al. (2013). Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy, 33(8), 827–837.CrossRef
Konig, Spira D., Demuth, I., Steinhagen-Thiessen, E., & Norman, K. (2018). Polypharmacy as a risk factor for clinically relevant sarcopenia: Results from Berlin ageing study. The Journals of Gerontology, 73, 117–122.CrossRef
Laflamme, L., Monárrez-Espino, J., Johnell, K., et al. (2015). Type, number or both? A population-based matched case-control study on the risk of fall injuries among older people and number of medications beyond fall-inducing drugs. PLoS ONE, 10(3), e0123390.CrossRef
Lindblad, C., Hanlon, J., Gross, C., et al. (2006). Clinically important drug-disease interactions and their prevalence in older adults. Clinical Therapeutics, 28(8), 1133–1143.CrossRef
Mair, A. (2019). Medication safety in polypharmacy. Geneva: Third Global Patient Safety Challenge Rep., World Health Organ.
Mair, A., Wilson, M., & Drescruilte, T. (2019). Addressing the challenge of polypharmacy. Annual Review of Pharmacology and Toxicology, 60, 661–681. www.​annualreviews.​org
Masnoon, N., Shakib, S., Kalisch-Ellett, L., & Caughey, G. E. (2017). What is polypharmacy? A systematic review of definitions. BMC Geriatrics., 17, 230.CrossRef
Maust, D. T., Kim, H. M., Seyfried, L. S., Chiang, C., Kavanagh, J., et al. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry, 72(5), 438–445.CrossRef
Nishtala, P., Salahudeen, M., & Hilmer, S. (2016). Anticholinergics: Theoretical and clinical overview. Expert Opinion on Drug Safety, 15(6), 753–768.CrossRef
O’Loughlin, J. L., Robitaille, Y., Boivin, J. F., & Suissa, S. (1993). Incidence of and risk factors for falls and injurious falls among the community dwelling elderly. American Journal of Epidemiology, 137, 342–354.CrossRef
Ornestein, S. M., Nietert, P. J., Jenkins, R. G., & Litvin, C. B. (2013). The prevalence of chronic diseases and multimorbidity in primary care practice: A PPRNet report. Journal of the American Board of Family Practice, 26(5), 518–524.CrossRef
Panagioti, M., Stokes, J., Esmail, A., Coventry, P., Cheraghi-Sohi, S., et al. (2015). Multimorbidity and patient safety incidents in primary care: a systematic review and meta-analysis. PLOS ONE, 10(8):e0135947
PGEU (Pharm. Group Eur. Union). (2008). Targeting adherence: Improving patient outcomes in Europe through community pharmacists’ intervention. Policy Statement, Pharm: Group Eur. Union, Brussels.
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., et al. (2004). Adverse drug reactions as cause of admission to hospital: Prospective analysis of 18 820 patients. BMJ, 329(7456), 15–19.CrossRef
Pub. Health Engl. (2014). Advice for prescribers on the risk of the misuse of pregabalin and gabapentin. Fact Sheet, Pub. Health Engl., London
Qaseem, A., Wilt, T., Kansagara, D., Horwitch, C., Barry, M., & Forciea, M. (2018). Haemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: A guidance statement update from the American College of Physicians. Annals of Internal Medicine, 168(8), 569–576.CrossRef
Rawlins, M. D., & Thompson, J. W. (1977). Pathogenesis of adverse drug reactions. In D. M. Davies (Ed.), Textbook of adverse drug reactions (pp. 10–17). Oxford, UK: Oxford University Press.
Risacher, S. L., McDonald, B. C., Tallman, E. F., West, J. D., Farlow, M. R., et al. (2016). Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults. JAMA Neurology, 73(6), 721–732.CrossRef
Routledge, P., WHO. (2019). Medication saftey in high risk situations. Geneva. World Health Org.
Saum, K. U., Schottker, B., Meid, A. D., Holleczek, B., Haefeli, W. E., et al. (2017). Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study. Journal of the American Geriatrics Society, 65(2), e27–e32.CrossRef
Shippee, N. D., Shah, N. D., May, C. R., Mair, F. S., & Montori, V. M. (2012). Cumulative complexity: A functional, patient-centered model of patient complexity can improve research and practice. Journal of Clinical Epidemiology, 65(10), 1041–1051.CrossRef
SIMPATHY. (2017). SIMPATHY economic tool. Econ. Tool, SIMPATHY Consort., Scotland.
Stewart, D., Mair, A., Wilson, M., Kardas, P., Lewek, P., et al. (2016). Guidance to manage inappropriate polypharmacy in older people: Systematic review and future developments. Expert Opinion on Drug Safety, 16(2), 203–213
Sutaria, A., Lui, L., & Ahmed, Z. (2016). Multiple medication (polypharmacy) and chronic kidney disease in patients aged 60 and older: A pharmacoepidemiologic perspective. Therapeutic Advances in Cardiovascular Disease, 10(4), 242–250.CrossRef
Taber, D. J., et al. (2014). Clinical and economic outcomes associated with medication errors in kidney transplantation. Clinical Journal of the American Society of Nephrology, 9(5), 960–966.CrossRef
Valentijn, P. P., Schepman, S. M., Opheij, W., & Bruijnzeels, M. A. (2013). Understanding integrated care: A comprehensive conceptual framework based on the integrative functions of primary care. International Journal of Integrated Care, 13, e010. PMID: 23687482.CrossRef
van den Bussche, H., Schön, G., Kolonko, T., Hansen, H., Wegscheider, K., et al. (2011). Patterns of ambulatory medical care utilisation in elderly patients with special reference to chronic disease and multimorbidity—Results from a claims data based observational study in Germany. BMC Geriatrics, 11, 54.CrossRef
Wills, S. (2005). Drugs of abuse (2nd ed.). London: Pharmaceutical Press.
World Health Organ. (2017). Medication without harm. Geneva: Glob. Patient Saf. Chall., World Health Organ.
Metadaten
Titel
Polypharmacy and Integrated Care
verfasst von
Alpana Mair
Albert Alonso
Copyright-Jahr
2021
Buch
Handbook Integrated Care

Print ISBN: 978-3-030-69261-2

Electronic ISBN: 978-3-030-69262-9

Copyright-Jahr: 2021

DOI
https://doi.org/10.1007/978-3-030-69262-9_27

Premium Partner

    Bildnachweise